1 Market Overview

1.1 Product Overview and Scope of Microbiome Therapeutics

1.2 Classification of Microbiome Therapeutics by Type

1.2.1 Overview: Global Microbiome Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Microbiome Therapeutics Revenue Market Share by Type in 2021

1.2.3 Upper GIT

1.2.4 Lower GIT

1.3 Global Microbiome Therapeutics Market by Application

1.3.1 Overview: Global Microbiome Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 C. difficile Infection (CDI)

1.3.3 Inflammatory Bowel Disease (IBD)

1.3.4 Orphan Drug

1.3.5 Immuno-oncology

1.3.6 Others

1.4 Global Microbiome Therapeutics Market Size & Forecast

1.5 Global Microbiome Therapeutics Market Size and Forecast by Region

1.5.1 Global Microbiome Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Microbiome Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Microbiome Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Microbiome Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Microbiome Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Microbiome Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Microbiome Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Microbiome Therapeutics Market Drivers

1.6.2 Microbiome Therapeutics Market Restraints

1.6.3 Microbiome Therapeutics Trends Analysis

2 Company Profiles

2.1 Seres Therapeutics

2.1.1 Seres Therapeutics Details

2.1.2 Seres Therapeutics Major Business

2.1.3 Seres Therapeutics Microbiome Therapeutics Product and Solutions

2.1.4 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Seres Therapeutics Recent Developments and Future Plans

2.2 Assembly Biosciences

2.2.1 Assembly Biosciences Details

2.2.2 Assembly Biosciences Major Business

2.2.3 Assembly Biosciences Microbiome Therapeutics Product and Solutions

2.2.4 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Assembly Biosciences Recent Developments and Future Plans

2.3 Synthetic Biologics

2.3.1 Synthetic Biologics Details

2.3.2 Synthetic Biologics Major Business

2.3.3 Synthetic Biologics Microbiome Therapeutics Product and Solutions

2.3.4 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Synthetic Biologics Recent Developments and Future Plans

2.4 Interxon

2.4.1 Interxon Details

2.4.2 Interxon Major Business

2.4.3 Interxon Microbiome Therapeutics Product and Solutions

2.4.4 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Interxon Recent Developments and Future Plans

2.5 PureTech

2.5.1 PureTech Details

2.5.2 PureTech Major Business

2.5.3 PureTech Microbiome Therapeutics Product and Solutions

2.5.4 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 PureTech Recent Developments and Future Plans

2.6 Synlogic

2.6.1 Synlogic Details

2.6.2 Synlogic Major Business

2.6.3 Synlogic Microbiome Therapeutics Product and Solutions

2.6.4 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Synlogic Recent Developments and Future Plans

2.7 Enterome BioScience

2.7.1 Enterome BioScience Details

2.7.2 Enterome BioScience Major Business

2.7.3 Enterome BioScience Microbiome Therapeutics Product and Solutions

2.7.4 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Enterome BioScience Recent Developments and Future Plans

2.8 4D Pharma

2.8.1 4D Pharma Details

2.8.2 4D Pharma Major Business

2.8.3 4D Pharma Microbiome Therapeutics Product and Solutions

2.8.4 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 4D Pharma Recent Developments and Future Plans

2.9 Second Genome

2.9.1 Second Genome Details

2.9.2 Second Genome Major Business

2.9.3 Second Genome Microbiome Therapeutics Product and Solutions

2.9.4 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Second Genome Recent Developments and Future Plans

2.10 AOBiome

2.10.1 AOBiome Details

2.10.2 AOBiome Major Business

2.10.3 AOBiome Microbiome Therapeutics Product and Solutions

2.10.4 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AOBiome Recent Developments and Future Plans

2.11 C3 Jian

2.11.1 C3 Jian Details

2.11.2 C3 Jian Major Business

2.11.3 C3 Jian Microbiome Therapeutics Product and Solutions

2.11.4 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 C3 Jian Recent Developments and Future Plans

2.12 Rebiotix

2.12.1 Rebiotix Details

2.12.2 Rebiotix Major Business

2.12.3 Rebiotix Microbiome Therapeutics Product and Solutions

2.12.4 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Rebiotix Recent Developments and Future Plans

2.13 MicroBiome Therapeutics LLC

2.13.1 MicroBiome Therapeutics LLC Details

2.13.2 MicroBiome Therapeutics LLC Major Business

2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions

2.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans

2.14 Metabiomics

2.14.1 Metabiomics Details

2.14.2 Metabiomics Major Business

2.14.3 Metabiomics Microbiome Therapeutics Product and Solutions

2.14.4 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Metabiomics Recent Developments and Future Plans

2.15 Ritter Pharmaceuticals

2.15.1 Ritter Pharmaceuticals Details

2.15.2 Ritter Pharmaceuticals Major Business

2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions

2.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Ritter Pharmaceuticals Recent Developments and Future Plans

2.16 Symberix

2.16.1 Symberix Details

2.16.2 Symberix Major Business

2.16.3 Symberix Microbiome Therapeutics Product and Solutions

2.16.4 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Symberix Recent Developments and Future Plans

2.17 OpenBiome

2.17.1 OpenBiome Details

2.17.2 OpenBiome Major Business

2.17.3 OpenBiome Microbiome Therapeutics Product and Solutions

2.17.4 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 OpenBiome Recent Developments and Future Plans

2.18 Azitra

2.18.1 Azitra Details

2.18.2 Azitra Major Business

2.18.3 Azitra Microbiome Therapeutics Product and Solutions

2.18.4 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Azitra Recent Developments and Future Plans

2.19 Symbiotix Biotherapies

2.19.1 Symbiotix Biotherapies Details

2.19.2 Symbiotix Biotherapies Major Business

2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions

2.19.4 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Symbiotix Biotherapies Recent Developments and Future Plans

2.20 Osel

2.20.1 Osel Details

2.20.2 Osel Major Business

2.20.3 Osel Microbiome Therapeutics Product and Solutions

2.20.4 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Osel Recent Developments and Future Plans

2.21 Metabogen

2.21.1 Metabogen Details

2.21.2 Metabogen Major Business

2.21.3 Metabogen Microbiome Therapeutics Product and Solutions

2.21.4 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Metabogen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Microbiome Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Microbiome Therapeutics Players Market Share in 2021

3.2.2 Top 10 Microbiome Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Microbiome Therapeutics Players Head Office, Products and Services Provided

3.4 Microbiome Therapeutics Mergers & Acquisitions

3.5 Microbiome Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Microbiome Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Microbiome Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Microbiome Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Microbiome Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Microbiome Therapeutics Revenue by Type (2017-2028)

6.2 North America Microbiome Therapeutics Revenue by Application (2017-2028)

6.3 North America Microbiome Therapeutics Market Size by Country

6.3.1 North America Microbiome Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Microbiome Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Microbiome Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Microbiome Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Microbiome Therapeutics Revenue by Type (2017-2028)

7.2 Europe Microbiome Therapeutics Revenue by Application (2017-2028)

7.3 Europe Microbiome Therapeutics Market Size by Country

7.3.1 Europe Microbiome Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Microbiome Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Microbiome Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Microbiome Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Microbiome Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Microbiome Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Microbiome Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Microbiome Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region

8.3.1 Asia-Pacific Microbiome Therapeutics Revenue by Region (2017-2028)

8.3.2 China Microbiome Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Microbiome Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Microbiome Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Microbiome Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Microbiome Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Microbiome Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Microbiome Therapeutics Revenue by Type (2017-2028)

9.2 South America Microbiome Therapeutics Revenue by Application (2017-2028)

9.3 South America Microbiome Therapeutics Market Size by Country

9.3.1 South America Microbiome Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Microbiome Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Microbiome Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Microbiome Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Microbiome Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country

10.3.1 Middle East & Africa Microbiome Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Microbiome Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Microbiome Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Microbiome Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Microbiome Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Microbiome Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Microbiome Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Microbiome Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Microbiome Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Seres Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Seres Therapeutics Major Business

Table 8. Seres Therapeutics Microbiome Therapeutics Product and Solutions

Table 9. Seres Therapeutics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Assembly Biosciences Corporate Information, Head Office, and Major Competitors

Table 11. Assembly Biosciences Major Business

Table 12. Assembly Biosciences Microbiome Therapeutics Product and Solutions

Table 13. Assembly Biosciences Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Synthetic Biologics Corporate Information, Head Office, and Major Competitors

Table 15. Synthetic Biologics Major Business

Table 16. Synthetic Biologics Microbiome Therapeutics Product and Solutions

Table 17. Synthetic Biologics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Interxon Corporate Information, Head Office, and Major Competitors

Table 19. Interxon Major Business

Table 20. Interxon Microbiome Therapeutics Product and Solutions

Table 21. Interxon Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. PureTech Corporate Information, Head Office, and Major Competitors

Table 23. PureTech Major Business

Table 24. PureTech Microbiome Therapeutics Product and Solutions

Table 25. PureTech Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Synlogic Corporate Information, Head Office, and Major Competitors

Table 27. Synlogic Major Business

Table 28. Synlogic Microbiome Therapeutics Product and Solutions

Table 29. Synlogic Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Enterome BioScience Corporate Information, Head Office, and Major Competitors

Table 31. Enterome BioScience Major Business

Table 32. Enterome BioScience Microbiome Therapeutics Product and Solutions

Table 33. Enterome BioScience Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. 4D Pharma Corporate Information, Head Office, and Major Competitors

Table 35. 4D Pharma Major Business

Table 36. 4D Pharma Microbiome Therapeutics Product and Solutions

Table 37. 4D Pharma Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Second Genome Corporate Information, Head Office, and Major Competitors

Table 39. Second Genome Major Business

Table 40. Second Genome Microbiome Therapeutics Product and Solutions

Table 41. Second Genome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AOBiome Corporate Information, Head Office, and Major Competitors

Table 43. AOBiome Major Business

Table 44. AOBiome Microbiome Therapeutics Product and Solutions

Table 45. AOBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. C3 Jian Corporate Information, Head Office, and Major Competitors

Table 47. C3 Jian Major Business

Table 48. C3 Jian Microbiome Therapeutics Product and Solutions

Table 49. C3 Jian Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Rebiotix Corporate Information, Head Office, and Major Competitors

Table 51. Rebiotix Major Business

Table 52. Rebiotix Microbiome Therapeutics Product and Solutions

Table 53. Rebiotix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. MicroBiome Therapeutics LLC Corporate Information, Head Office, and Major Competitors

Table 55. MicroBiome Therapeutics LLC Major Business

Table 56. MicroBiome Therapeutics LLC Microbiome Therapeutics Product and Solutions

Table 57. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Metabiomics Corporate Information, Head Office, and Major Competitors

Table 59. Metabiomics Major Business

Table 60. Metabiomics Microbiome Therapeutics Product and Solutions

Table 61. Metabiomics Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Ritter Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. Ritter Pharmaceuticals Major Business

Table 64. Ritter Pharmaceuticals Microbiome Therapeutics Product and Solutions

Table 65. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Symberix Corporate Information, Head Office, and Major Competitors

Table 67. Symberix Major Business

Table 68. Symberix Microbiome Therapeutics Product and Solutions

Table 69. Symberix Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. OpenBiome Corporate Information, Head Office, and Major Competitors

Table 71. OpenBiome Major Business

Table 72. OpenBiome Microbiome Therapeutics Product and Solutions

Table 73. OpenBiome Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Azitra Corporate Information, Head Office, and Major Competitors

Table 75. Azitra Major Business

Table 76. Azitra Microbiome Therapeutics Product and Solutions

Table 77. Azitra Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Symbiotix Biotherapies Corporate Information, Head Office, and Major Competitors

Table 79. Symbiotix Biotherapies Major Business

Table 80. Symbiotix Biotherapies Microbiome Therapeutics Product and Solutions

Table 81. Symbiotix Biotherapies Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Osel Corporate Information, Head Office, and Major Competitors

Table 83. Osel Major Business

Table 84. Osel Microbiome Therapeutics Product and Solutions

Table 85. Osel Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Metabogen Corporate Information, Head Office, and Major Competitors

Table 87. Metabogen Major Business

Table 88. Metabogen Microbiome Therapeutics Product and Solutions

Table 89. Metabogen Microbiome Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Global Microbiome Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 91. Global Microbiome Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 92. Breakdown of Microbiome Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Microbiome Therapeutics Players Head Office, Products and Services Provided

Table 94. Microbiome Therapeutics Mergers & Acquisitions in the Past Five Years

Table 95. Microbiome Therapeutics New Entrants and Expansion Plans

Table 96. Global Microbiome Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 97. Global Microbiome Therapeutics Revenue Share by Type (2017-2022)

Table 98. Global Microbiome Therapeutics Revenue Forecast by Type (2023-2028)

Table 99. Global Microbiome Therapeutics Revenue by Application (2017-2022)

Table 100. Global Microbiome Therapeutics Revenue Forecast by Application (2023-2028)

Table 101. North America Microbiome Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 102. North America Microbiome Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 103. North America Microbiome Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 104. North America Microbiome Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 105. North America Microbiome Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 106. North America Microbiome Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 107. Europe Microbiome Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 108. Europe Microbiome Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 109. Europe Microbiome Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 110. Europe Microbiome Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 111. Europe Microbiome Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 112. Europe Microbiome Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 113. Asia-Pacific Microbiome Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 114. Asia-Pacific Microbiome Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 115. Asia-Pacific Microbiome Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 116. Asia-Pacific Microbiome Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 117. Asia-Pacific Microbiome Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 118. Asia-Pacific Microbiome Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 119. South America Microbiome Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 120. South America Microbiome Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 121. South America Microbiome Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 122. South America Microbiome Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 123. South America Microbiome Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 124. South America Microbiome Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 125. Middle East & Africa Microbiome Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 126. Middle East & Africa Microbiome Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 127. Middle East & Africa Microbiome Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 128. Middle East & Africa Microbiome Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 129. Middle East & Africa Microbiome Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 130. Middle East & Africa Microbiome Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Microbiome Therapeutics Picture

Figure 2. Global Microbiome Therapeutics Revenue Market Share by Type in 2021

Figure 3. Upper GIT

Figure 4. Lower GIT

Figure 5. Microbiome Therapeutics Revenue Market Share by Application in 2021

Figure 6. C. difficile Infection (CDI) Picture

Figure 7. Inflammatory Bowel Disease (IBD) Picture

Figure 8. Orphan Drug Picture

Figure 9. Immuno-oncology Picture

Figure 10. Others Picture

Figure 11. Global Microbiome Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Microbiome Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Microbiome Therapeutics Revenue Market Share by Region (2017-2028)

Figure 14. Global Microbiome Therapeutics Revenue Market Share by Region in 2021

Figure 15. North America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Microbiome Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Microbiome Therapeutics Market Drivers

Figure 21. Microbiome Therapeutics Market Restraints

Figure 22. Microbiome Therapeutics Market Trends

Figure 23. Seres Therapeutics Recent Developments and Future Plans

Figure 24. Assembly Biosciences Recent Developments and Future Plans

Figure 25. Synthetic Biologics Recent Developments and Future Plans

Figure 26. Interxon Recent Developments and Future Plans

Figure 27. PureTech Recent Developments and Future Plans

Figure 28. Synlogic Recent Developments and Future Plans

Figure 29. Enterome BioScience Recent Developments and Future Plans

Figure 30. 4D Pharma Recent Developments and Future Plans

Figure 31. Second Genome Recent Developments and Future Plans

Figure 32. AOBiome Recent Developments and Future Plans

Figure 33. C3 Jian Recent Developments and Future Plans

Figure 34. Rebiotix Recent Developments and Future Plans

Figure 35. MicroBiome Therapeutics LLC Recent Developments and Future Plans

Figure 36. Metabiomics Recent Developments and Future Plans

Figure 37. Ritter Pharmaceuticals Recent Developments and Future Plans

Figure 38. Symberix Recent Developments and Future Plans

Figure 39. OpenBiome Recent Developments and Future Plans

Figure 40. Azitra Recent Developments and Future Plans

Figure 41. Symbiotix Biotherapies Recent Developments and Future Plans

Figure 42. Osel Recent Developments and Future Plans

Figure 43. Metabogen Recent Developments and Future Plans

Figure 44. Global Microbiome Therapeutics Revenue Share by Players in 2021

Figure 45. Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 46. Global Top 3 Players Microbiome Therapeutics Revenue Market Share in 2021

Figure 47. Global Top 10 Players Microbiome Therapeutics Revenue Market Share in 2021

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 49. Global Microbiome Therapeutics Revenue Share by Type in 2021

Figure 50. Global Microbiome Therapeutics Market Share Forecast by Type (2023-2028)

Figure 51. Global Microbiome Therapeutics Revenue Share by Application in 2021

Figure 52. Global Microbiome Therapeutics Market Share Forecast by Application (2023-2028)

Figure 53. North America Microbiome Therapeutics Sales Market Share by Type (2017-2028)

Figure 54. North America Microbiome Therapeutics Sales Market Share by Application (2017-2028)

Figure 55. North America Microbiome Therapeutics Revenue Market Share by Country (2017-2028)

Figure 56. United States Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Canada Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Mexico Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Europe Microbiome Therapeutics Sales Market Share by Type (2017-2028)

Figure 60. Europe Microbiome Therapeutics Sales Market Share by Application (2017-2028)

Figure 61. Europe Microbiome Therapeutics Revenue Market Share by Country (2017-2028)

Figure 62. Germany Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. France Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. United Kingdom Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Russia Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Italy Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Asia-Pacific Microbiome Therapeutics Sales Market Share by Type (2017-2028)

Figure 68. Asia-Pacific Microbiome Therapeutics Sales Market Share by Application (2017-2028)

Figure 69. Asia-Pacific Microbiome Therapeutics Revenue Market Share by Region (2017-2028)

Figure 70. China Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Japan Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South Korea Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. India Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Southeast Asia Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Australia Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South America Microbiome Therapeutics Sales Market Share by Type (2017-2028)

Figure 77. South America Microbiome Therapeutics Sales Market Share by Application (2017-2028)

Figure 78. South America Microbiome Therapeutics Revenue Market Share by Country (2017-2028)

Figure 79. Brazil Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Argentina Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Middle East and Africa Microbiome Therapeutics Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Microbiome Therapeutics Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Microbiome Therapeutics Revenue Market Share by Country (2017-2028)

Figure 84. Turkey Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Saudi Arabia Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. UAE Microbiome Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source